Literature DB >> 1530019

Effect of magnesium sulfate on maternal brain blood flow in preeclampsia: a randomized, placebo-controlled study.

M A Belfort1, K J Moise.   

Abstract

OBJECTIVES: The purpose of this study was to determine the effect of a 6 gm intravenous bolus of magnesium sulfate on maternal brain blood flow velocity waveforms in patients with preeclampsia. STUDY
DESIGN: Twelve patients with preeclampsia were randomized to two groups and studied with Doppler ultrasonography before and immediately after infusion of either a 6 gm intravenous loading dose of magnesium sulfate or a placebo. The middle cerebral, common carotid, and internal carotid arteries were studied.
RESULTS: Magnesium sulfate significantly reduced the pulsatility index in the middle cerebral artery (change in pulsatility index = -0.16 + 0.09) when compared with the placebo (change in pulsatility index = -0.02 + 0.06), p = 0.01. There were no significant changes in the Doppler indexes of the carotid vessels.
CONCLUSIONS: These data suggest that magnesium sulfate vasodilates the smaller-diameter intracranial vessels distal to the middle cerebral artery and may exert its main effect in the prophylaxis and treatment of eclampsia by relieving cerebral ischemia.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1530019     DOI: 10.1016/s0002-9378(11)91567-1

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  21 in total

1.  Magnesium sulphate and pre-eclampsia. Trial needed to see whether it's as valuable in pre-eclampsia as in eclampsia.

Authors:  L Duley; J P Neilson
Journal:  BMJ       Date:  1999-07-03

Review 2.  Magnesium neuroprotection is limited in humans with acute brain injury.

Authors:  J Andrew McKee; Randall P Brewer; Gary E Macy; Cecil O Borel; James D Reynolds; David S Warner
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

Review 3.  Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema.

Authors:  W S Bartynski
Journal:  AJNR Am J Neuroradiol       Date:  2008-04-10       Impact factor: 3.825

Review 4.  Magnesium sulfate in eclampsia and pre-eclampsia: pharmacokinetic principles.

Authors:  J F Lu; C H Nightingale
Journal:  Clin Pharmacokinet       Date:  2000-04       Impact factor: 6.447

Review 5.  Role of magnesium sulfate in seizure prevention in patients with eclampsia and pre-eclampsia.

Authors:  J Anthony; R B Johanson; L Duley
Journal:  Drug Saf       Date:  1996-09       Impact factor: 5.606

6.  Serum magnesium levels as related to symptomatic vasospasm and outcome following aneurysmal subarachnoid hemorrhage.

Authors:  Frederic P Collignon; Jonathan A Friedman; David G Piepgras; Mark A Pichelmann; Jon I McIver; L Gerard Toussaint; Robyn L McClelland
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

Review 7.  Magnesium for neuroprotection in ischaemic stroke: rationale for use and evidence of effectiveness.

Authors:  K W Muir
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

8.  Assessment of the effects of endothelin-1 and magnesium sulphate on regional blood flows in conscious rats, by the coloured microsphere reference technique.

Authors:  P A Kemp; S M Gardiner; J E March; P C Rubin; T Bennett
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

9.  Modern management of eclampsia.

Authors:  O Salha; J J Walker
Journal:  Postgrad Med J       Date:  1999-02       Impact factor: 2.401

Review 10.  Magnesium sulfate for the treatment of eclampsia: a brief review.

Authors:  Anna G Euser; Marilyn J Cipolla
Journal:  Stroke       Date:  2009-02-10       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.